State Ledger
Company profile

ANAPTYSBIO, INC CIK 1370053

Ticker
ANAB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92121
Fiscal year end
2026 (FY)
Market Data
Close
$45.96
Change
-$0.31
Change %
-0.67%
Volume
44,505

ANAB · trading date Oct 9, 2026 · previous close $46.27 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
—
Total assets
$316.98M
Total liabilities
—
Stockholders' equity
$10.59M
Cash & equivalents
$133.83M
Operating income
—
Operating cash flow
—
Capital expenditures
—

Fiscal year 2026, via 10-KT filed 2026-09-21. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
3.3%
CapEx / revenue
—
Operating cash flow / net income
—

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 — — $316.98M — $10.59M
2025 $234.60M -$13.23M $364.40M — $37.21M
2024 $91.28M -$145.23M $483.83M — $70.87M
2023 $17.16M -$163.62M $452.39M — $88.10M
2022 $10.29M -$128.72M $610.38M — $262.10M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-KT
filed 2026-09-21

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92121
10770 WATERIDGE CIRCLE, SUITE 210
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies